RAJAF News
Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.
| Date | Type | Publisher | Headline | Summary |
|---|---|---|---|---|
| 2026-07-27 | Foreign issuer report | SEC filing | TFA Therapeutics, Inc. filed Form 6-K | TFA Therapeutics, Inc. filed Form 6-K. |
| 2026-06-25 | Foreign issuer report | SEC filing | TFA Therapeutics, Inc. filed Form 6-K | TFA Therapeutics, Inc. filed Form 6-K. |
| 2025-11-26 | Foreign issuer report | SEC filing | TFA Therapeutics, Inc. filed Form 6-K | TFA Therapeutics, Inc. filed Form 6-K. |
| 2024-12-06 | Foreign issuer report | SEC filing | TFA Therapeutics, Inc. filed Form 6-K | TFA Therapeutics, Inc. filed Form 6-K. |
| 2024-03-19 | Foreign issuer report | SEC filing | TFA Therapeutics, Inc. filed Form 6-K | TFA Therapeutics, Inc. filed Form 6-K. |
| 2023-11-13 | Foreign issuer report | SEC filing | TFA Therapeutics, Inc. filed Form 6-K | TFA Therapeutics, Inc. filed Form 6-K. |
| 2023-09-28 | Foreign issuer report | SEC filing | TFA Therapeutics, Inc. filed Form 6-K | TFA Therapeutics, Inc. filed Form 6-K. |